Papers/PMID:27324590
Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.
International journal of food sciences and nutrition2016The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
(-)-epigallocatechin 3-gallate — decreases LDL cholesterol
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“According to weighted mean differences for changes from baseline with 95% confidence intervals (CI), 107-856 mg/d of EGCG for 4 to 14 weeks reduced LDL-C by -9.29 mg/dl (95% CI, -12.27 to -6.31).”
Quoted verbatim from Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.. - Study
- meta-analysis
- Dose
- 107-856 mg/d for 4 to 14 weeks
- Population
- healthy individuals, pooled across 17 randomized controlled trials of EGCG for 4 to 14 weeks
Effect -9.29 mean difference, 95% CI -12.27 to -6.31
Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.2016PMID:27324590